Clinical Trial Update: Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating levosimendan in patients who had a heart attack and undergone catheterization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Hospital Universitario de Canarias | Conditions: ST Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN